1-11 of 11
Ayad Al-Katib
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1a/1b Trial of ST-001, a Fenretinide Phospholipid Suspension for 4-Hour Intravenous Infusion in Relapsed/Refractory T-Cell Non-Hodgkin's Lymphoma

Ayad Al-Katib, MD, Timothy M. Kuzel, MD, Ralph Parchment, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4041.
https://doi.org/10.1182/blood-2019-127278
Published: 2019
Journal Articles

Isolation and Characterization of a CD34 + Sub-Clone in B-Cell Lymphoma

Ayad Al-Katib, MD, Ebrahim Abdul Shukkur, PhD, Ali M Gabali, MD PhD, ALI Raufi, MD, Salah Ebrahim, MD, Mustapha Kandouz, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3970.
https://doi.org/10.1182/blood-2019-130738
Published: 2019
Journal Articles

The Utility of End of Treatment PET-CT in Patients with Diffuse Large B-Cell Lymphoma and Documented Complete Remission By Interim PET

Dahlia Sano, MBBCH, Susan Szpunar, Kleanthe Kolizeras, Ayad Al-Katib, MD FACP
Journal: Blood
Blood (2017) 130 (Supplement 1): 4702.
https://doi.org/10.1182/blood.V130.Suppl_1.4702.4702
Published: 2017
Journal Articles

The BCL2 Targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 Is Active in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma

Wael A. Harb, MD, Nehal Lakhani, MD PhD, Ana Logsdon, LPN, Clinical Research Coordinator, Mary Steigelman, RN, Heidi Smith-Green, BSN, RN, Shari Gaylor, RN, Wendi Rodrigueza, PhD, Michael Woolliscroft, BA, MBA, Mina Sooch, BS, MBA, Richard A. Messmann, MD MHS, MSc, Ayad Al-Katib, MD FACP
Journal: Blood
Blood (2014) 124 (21): 1716.
https://doi.org/10.1182/blood.V124.21.1716.1716
Published: 2014
Journal Articles

The BCL2 Targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 Is Active In Patients With Relapsed Or Refractory Non-Hodgkin’s Lymphoma

Wael A. Harb, MD, Nehal Lakhani, MD, PhD, Ana Logsdon, LPN, Clinical Research Coordinator, Mary Steigelman, RN, Heidi Smith-Green, BSN, RN, Shari Gaylor, RN, Michael Woolliscroft, BA, MBA, Wendi Rodrigueza, Ph.D., Mina Sooch, BS, MBA, Richard A. Messmann, MD, MHS, MSc, Ayad Al-Katib, MD, FACP
Journal: Blood
Blood (2013) 122 (21): 88.
https://doi.org/10.1182/blood.V122.21.88.88
Published: 2013
Journal Articles

Anti CD-20 Radioimmunotherapy (RIT) Can Be Safely and Effectively Delivered in a Community-Based Hospital

Ayad Al-Katib, MD, FACP, Mary Mandziara, NP, Susan Szpunar, PhD, Kleanthe Kolizeras, BS, Mary Steigelman, RN, John Kalabat, MD, Zyad Kafri, MD
Journal: Blood
Blood (2011) 118 (21): 4991.
https://doi.org/10.1182/blood.V118.21.4991.4991
Published: 2011
Journal Articles

Development of a Novel Small Molecule CRM-1 Inhibitor for Non Hodgkin's Lymphoma

Asfar Sohail Azmi, Research Associate, Ayad Al-Katib, MD, FACP, Amro Aboukameel, RA, Michael Kauffman, MD, Ph.D., Dilara McCauley, Research Associate, Ramzi Mohammad, PhD, Sharon Shacham, PhD
Journal: Blood
Blood (2011) 118 (21): 598.
https://doi.org/10.1182/blood.V118.21.598.598
Published: 2011
Journal Articles

The Utility of Bilateral Bone Marrow Biopsy in the Staging of Non-Hodgkin's Lymphoma

Zyad Kafri, MD, Marwan Al-Hajeili, MD, Muhammad I Zulfiqar, MD, FRCP(C), Asif S Shahab, MD, Abdul Mannan, MD, Susan Szpunar, PhD, Michelle Bonnett, MD, Ayad Al-Katib, MD, FACP
Journal: Blood
Blood (2011) 118 (21): 4769.
https://doi.org/10.1182/blood.V118.21.4769.4769
Published: 2011
Journal Articles

Surface Plasmon Resonance Study of Apoptotic Regulators Bcl-2, Bcl-w, Bcl-XL, and Mcl-1 Indicate That the Preclinical Small Molecule Inhibitor (SMI) TW-37 Binds to the Hydrophobic Groove Competitively with tBid To Form a Heterodimer Which Cannot Be Disrupted by 200-Fold Molar Excess of TW-37.

Anton-Scott Goustin, PhD, Anshu Giri, B.S., Shaomeng Wang, Ph.D., Ayad Al-Katib, M.D., Mohammad M. Ramzi, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 1606.
https://doi.org/10.1182/blood.V110.11.1606.1606
Published: 2007
Journal Articles

Phase 1 Study of Talabostat and Rituximab in Patients with Indolent Non-Hodgkin’s Lymphoma with Primary Resistance to or Progression Following Rituximab.

Ayad Al-Katib, MD, David D. Hurd, MD, Robert Raju, MD, Joe Stephenson, MD, Francis Giles, MD, Eric Haltom, Margaret J. Uprichard, PharmD
Journal: Blood
Blood (2004) 104 (11): 1403.
https://doi.org/10.1182/blood.V104.11.1403.1403
Published: 2004
Journal Articles

The Novel Cyclin-Dependent Kinase Inhibitor Flavopiridol Downregulates Bcl-2 and Induces Growth Arrest and Apoptosis in Chronic B-Cell Leukemia Lines

Andrea König, Gary K. Schwartz, Ramzi M. Mohammad, Ayad Al-Katib, Janice L. Gabrilove
Journal: Blood
Blood (1997) 90 (11): 4307–4312.
https://doi.org/10.1182/blood.V90.11.4307
Published: 1997